Literature DB >> 1692923

Alpha 2-macroglobulin and serum preferentially counteract the mitoinhibitory effect of transforming growth factor-beta 2 in rat hepatocytes.

J LaMarre1, G K Wollenberg, J Gauldie, M A Hayes.   

Abstract

Transforming growth factors-beta 1 and beta 2 (TGF-beta 1 and TGF-beta 2) are potent, multifunctional modifiers of cellular proliferation and differentiation in many cell types. To evaluate factors which may alter the activity of the TGF-beta s during hepatocyte proliferation, we examined the influences of bovine serum and purified bovine or human alpha 2-macroglobulin (alpha 2M) on the mitoinhibitory effects of the TGF-beta in primary cultures of rat hepatocytes. The inhibitory activity of TGF-beta was evaluated by autoradiographic labeling index at 48 hours in hepatocyte cultures exposed to [3H]thymidine between hours 24 and 48 in culture. In the absence of serum or alpha 2M, TGF-beta 1 and TGF-beta 2 were equivalently potent in inhibiting S-phase DNA synthesis in hepatocytes cultured with or without epidermal growth factor. However, bovine serum and purified bovine or human alpha 2M consistently counteracted the mitoinhibitory effects of TGF-beta 2. S-phase DNA synthesis increased five- to six-fold when bovine serum (15%) or alpha 2M (200 micrograms/ml) were included with TGF-beta 2 (0.1 ng/ml) and epidermal growth factor (20 ng/ml). The mitoinhibitory effect of TGF-beta 1 was not influenced by the addition of purified bovine alpha 2M. Human alpha 2M or bovine serum counteracted inhibition by TGF-beta 1 to a lesser extent. [125I]TGF-beta 1 and 125I]TGF-beta 2 formed complexes with purified bovine alpha 2M and serum proteins migrating at identical positions to purified alpha 2M during nondenaturing polyacrylamide gel electrophoresis. However, [125I]TGF-beta 1 associated preferentially with the "fast" migrating form of alpha 2M, whereas [125I]TGF-beta 2 associated with both the "slow" and "fast" migrating forms. Inhibitory activity of TGF-beta 1 and TGF-beta 2 coeluted with alpha 2M in the high molecular weight fractions from a Sephacryl S-200 column. These results support the hypothesis that purified alpha 2M and alpha 2M in bovine serum binds both TGF-betas but preferentially counteracts the mitoinhibitory effect of TGF-beta 2 on rat hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1692923

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  15 in total

1.  Inflammatory and metalloproteinases profiles predict three-month poor outcomes in ischemic stroke treated with thrombolysis.

Authors:  Anna Maria Gori; Betti Giusti; Benedetta Piccardi; Patrizia Nencini; Vanessa Palumbo; Mascia Nesi; Antonia Nucera; Giovanni Pracucci; Paolina Tonelli; Eleonora Innocenti; Alice Sereni; Elena Sticchi; Danilo Toni; Paolo Bovi; Mario Guidotti; Maria Rosaria Tola; Domenico Consoli; Giuseppe Micieli; Rossana Tassi; Giovanni Orlandi; Maria Sessa; Francesco Perini; Maria Luisa Delodovici; Maria Luisa Zedde; Francesca Massaro; Rosanna Abbate; Domenico Inzitari
Journal:  J Cereb Blood Flow Metab       Date:  2017-03-07       Impact factor: 6.200

Review 2.  Regulation of the Bioavailability of TGF-β and TGF-β-Related Proteins.

Authors:  Ian B Robertson; Daniel B Rifkin
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-06-01       Impact factor: 10.005

3.  Effect of alpha2-macroglobulin on retinal glial cell proliferation.

Authors:  Ivan Milenkovic; Gerd Birkenmeier; Peter Wiedemann; Andreas Reichenbach; Andreas Bringmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-04-15       Impact factor: 3.117

Review 4.  Hepatic fibrosis--current concepts of pathogenesis and therapy.

Authors:  B Högemann; W Domschke
Journal:  Gastroenterol Jpn       Date:  1993-08

5.  Immunohistochemical localization of low density lipoprotein receptor-related protein 1 and alpha(2)-Macroglobulin in retinal and choroidal tissue of proliferative retinopathies.

Authors:  P F Barcelona; J D Luna; G A Chiabrando; C P Juarez; I A Bhutto; T Baba; D S McLeod; M C Sánchez; G A Lutty
Journal:  Exp Eye Res       Date:  2010-06-01       Impact factor: 3.467

6.  Alpha2-macroglobulin as a promising biomarker for cerebral small vessel disease in acute ischemic stroke patients.

Authors:  Tomohisa Nezu; Naohisa Hosomi; Shiro Aoki; Kazushi Deguchi; Hisashi Masugata; Noriko Ichihara; Hideo Ohyama; Toshiho Ohtsuki; Masakazu Kohno; Masayasu Matsumoto
Journal:  J Neurol       Date:  2013-07-23       Impact factor: 4.849

7.  Binding of transforming growth factor-beta 1 to methylamine-modified alpha 2-macroglobulin and to binary and ternary alpha 2-macroglobulin-proteinase complexes.

Authors:  S W Hall; J LaMarre; L B Marshall; M A Hayes; S L Gonias
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

8.  Evaluation of plasma alpha-2-macroglobulin and interactions with tumour necrosis factor-alpha in horses with endotoxemic signs.

Authors:  N Coté; D R Trout; A M Hayes
Journal:  Can J Vet Res       Date:  1996-04       Impact factor: 1.310

9.  Hepcidin bound to α2-macroglobulin reduces ferroportin-1 expression and enhances its activity at reducing serum iron levels.

Authors:  Michael Li-Hsuan Huang; Christopher J D Austin; Marie-Agnès Sari; Yohan Suryo Rahmanto; Prem Ponka; Daniel Vyoral; Des R Richardson
Journal:  J Biol Chem       Date:  2013-07-11       Impact factor: 5.157

10.  Shearing of synovial fluid activates latent TGF-β.

Authors:  M B Albro; A D Cigan; R J Nims; K J Yeroushalmi; S R Oungoulian; C T Hung; G A Ateshian
Journal:  Osteoarthritis Cartilage       Date:  2012-07-31       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.